You just read:

Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer

News provided by

Merck KGaA

Dec 10, 2018, 10:00 ET